肝病患者中克林霉素的消除情况。 - Suppr

Suppr

超能文献

Clindamycin elimination in patients with liver disease.

作者信息

Eng R H, Gorski S, Person A, Mangura C, Chmel H

出版信息

J Antimicrob Chemother. 1981 Oct;8(4):277-81. doi: 10.1093/jac/8.4.277.

DOI:10.1093/jac/8.4.277

PMID:6975271

Abstract

摘要

相似文献

Clindamycin elimination in patients with liver disease.肝病患者中克林霉素的消除情况。

J Antimicrob Chemother. 1981 Oct;8(4):277-81. doi: 10.1093/jac/8.4.277.

The effect of cirrhosis on the disposition and elimination of clindamycin.

Am J Dig Dis. 1975 Mar;20(3):223-30. doi: 10.1007/BF01070725.

[The pharmacokinetics of clindamycin in abnormal liver and renal function].[克林霉素在肝肾功能异常时的药代动力学]

Dtsch Med Wochenschr. 1972 Jul 14;97(28):1057-9. doi: 10.1055/s-0028-1107497.

[Pharmacological and clinical experiments in reversible liver cell insufficiency].[可逆性肝细胞功能不全的药理与临床实验]

Minerva Med. 1972 Jan 17;63(3):176-9.

[On the therapy of liver diseases with ornithine aspartate].

Med Klin. 1969;64(35):1541-4.

Serum levels of 5'-nucleotidase, bilirubin, alkaline phosphatase and transaminase in liver diseases--a comparative study.肝脏疾病中5'-核苷酸酶、胆红素、碱性磷酸酶及转氨酶的血清水平——一项对比研究。

Indian J Pathol Microbiol. 1987 Jan;30(1):55-67.

[Biochemical indices of the blood serum in various liver diseases].[各种肝脏疾病时血清的生化指标]

Ter Arkh. 1974;46(4):53-8.

Half-life of rifampicin after repeated administration of different doses in humans.利福平在人体重复给予不同剂量后的半衰期。

Chemotherapy. 1972;17(6):373-81. doi: 10.1159/000220873.

[Silymarin action in liver diseases].[水飞蓟素在肝脏疾病中的作用]

Med Klin. 1971 Sep 3;66(36):1204-8.

Liver injury and ascites in dengue.登革热中的肝损伤与腹水

J Assoc Physicians India. 2014 Mar;62(3):290-1.

引用本文的文献

Comparative pharmacokinetics of ceftazidime and moxalactam.头孢他啶和拉氧头孢的比较药代动力学

Antimicrob Agents Chemother. 1982 Aug;22(2):237-41. doi: 10.1128/AAC.22.2.237.

Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid.三种评估头孢他啶向血管外液渗透方法的同步比较。

Antimicrob Agents Chemother. 1982 Dec;22(6):995-8. doi: 10.1128/AAC.22.6.995.

Pharmacokinetics of ceftazidime in normal and uremic subjects.头孢他啶在正常人和尿毒症患者体内的药代动力学。

Antimicrob Agents Chemother. 1984 May;25(5):638-42. doi: 10.1128/AAC.25.5.638.

Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.头孢他啶在实验性肺炎链球菌、流感嗜血杆菌和大肠杆菌脑膜炎中的药代动力学及细菌学效应

Antimicrob Agents Chemother. 1983 Feb;23(2):213-7. doi: 10.1128/AAC.23.2.213.

Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics.β-内酰胺类抗菌药物扩散清除模型的性能受血管外蛋白质结合和组织液动力学的影响。

Antimicrob Agents Chemother. 1985 Sep;28(3):369-74. doi: 10.1128/AAC.28.3.369.

Pharmacokinetics and inflammatory fluid penetration of cefpodoxime proxetil in volunteers.头孢泊肟酯在志愿者体内的药代动力学及炎性液渗透情况

Antimicrob Agents Chemother. 1990 Feb;34(2):232-4. doi: 10.1128/AAC.34.2.232.

Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers.健康志愿者连续和间歇输注期间头孢他啶在血清和水疱抽吸液中的药代动力学。

Antimicrob Agents Chemother. 1990 Dec;34(12):2307-11. doi: 10.1128/AAC.34.12.2307.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验